Bob Harras
Bob Harras (born January 11, 1959) is an American comic book writer and editor. He is best known for his work with Marvel Comics and DC Comics. Harras has had a significant impact on the comic book industry, particularly during the 1990s.
Early Life and Career
Bob Harras was born in New York City. He began his career in the comic book industry in the early 1980s. Harras initially worked as an assistant editor at Marvel Comics, where he quickly rose through the ranks due to his keen editorial skills and understanding of the medium.
Marvel Comics
Harras is perhaps best known for his tenure at Marvel Comics, where he served as the editor-in-chief from 1995 to 2000. During his time at Marvel, Harras oversaw several major storylines and events, including the X-Men titles, which were among the company's best-selling books. He played a crucial role in the development of the X-Men franchise, working closely with writers and artists to shape the direction of the series.
Notable Works
Some of Harras's notable editorial and writing contributions at Marvel include:
- The X-Men crossover event "X-Cutioner's Song"
- The Avengers storyline "The Crossing"
- The relaunch of the Heroes Reborn line
DC Comics
After leaving Marvel, Harras joined DC Comics in 2010, where he was appointed as the editor-in-chief and senior vice president. At DC, Harras was involved in the The New 52 initiative, a major relaunch of the company's entire line of superhero comics. This initiative aimed to attract new readers and revitalize the DC Universe.
Legacy
Bob Harras's influence on the comic book industry is significant. His editorial decisions and creative direction have left a lasting impact on both Marvel and DC Comics. Harras is known for his ability to manage large crossover events and for his talent in nurturing creative talent within the industry.
Personal Life
Harras currently resides in New York City.
See Also
References
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
